Guide
As a qualified "anti-aging master", how can you not know the ever-changing life extension technology?
Pay attention to the time pie #chasing new express column, which contains the freshest life extension information and takes you to the first time to link the world's cutting-edge longevity technology trends.
With the widespread use of opioid analgesics, the problem of drug addiction is also increasing.
Recently, Marian Wilson's team at Washington State University found that hyperbaric oxygen therapy, which was originally used for anti-aging, is also quite effective in opioid withdrawal, reducing the dose of drugs and improving withdrawal symptoms, and the research results were published in the international journal Journal of Addictions Nursing.
Nine subjects with drug addiction problems received 90 minutes of hyperbaric oxygen therapy per day for 5 days while using methadone to relieve withdrawal symptoms.
The results showed that only 1 day after receiving hyperbaric adjuvant therapy, the subjects' withdrawal symptoms showed a significant improvement, and the intensity of symptoms was only half that of the control group. After 3 months, the subjects' dependence on the opioid methadone used for treatment decreased, with a dose reduction of 4.3 mg, compared with only 0.25 mg in the control group.
Researchers believe hyperbaric oxygen therapy can help alleviate pain and promise to reduce opioid use and addiction, and larger clinical trials are currently being planned.
—— TIMEPIE ——
Here is a time school that only does the most hard-core continuation research, focusing on "longevity technology" science. Day and night to read the literature to write only to bring you the latest, most comprehensive cutting-edge anti-aging information, welcome to leave your views and doubts in the comment area; day more motivation comes from your attention and sharing, anti-aging road with you side by side!
Read the original article
https://journals.lww.com/jan/Abstract/2022/01000/Hyperbaric_Oxygen_to_Assist_Adults_With_Opioid_Use.5.aspx%22